Loading insider details...
Beta
Latest Form 4 (Oct 8, 2026): Grant/Award of 20,990 TCRT shares, $15.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 8, 2026 | Alaunos Therapeutics, Inc. (TCRT) | Grant/Award | 20,990 | $15.6K |
| Jul 27, 2026 | Alaunos Therapeutics, Inc. (TCRT) | Grant/Award | 8,138 | $15.6K |
| Jun 24, 2026 | Inhibitor Therapeutics, Inc. (INTI) | Grant/Award | 50,000 | n/a |
| May 1, 2026 | Alaunos Therapeutics, Inc. (TCRT) | Grant/Award | 6,032 | $15.6K |
| Jan 15, 2026 | Alaunos Therapeutics, Inc. (TCRT) | Grant/Award | 5,406 | $15.6K |
| Nov 27, 2025 | Alaunos Therapeutics, Inc. (TCRT) | Grant/Award | 4,183 | $13.2K |
| Jul 17, 2025 | Alaunos Therapeutics, Inc. (TCRT) | Grant/Award | 10,000 | n/a |
| Apr 7, 2025 | Inhibitor Therapeutics, Inc. (INTI) | Grant/Award | 50,000 | n/a |
| Aug 29, 2024 | Telomir Pharmaceuticals, Inc. (TELO) | Grant/Award | 25,000 | n/a |
| May 16, 2024 | Inhibitor Therapeutics, Inc. (INTI) | Grant/Award | 50,000 | n/a |